GLP-1 Therapies, Pancreatitis and the MHRA: Unpicking the Evidence (Part 2)

The Causation Paradox in GLP-1 Pancreatitis Reporting

Dr Alison Cave, the chief safety officer at the MHRA, said:

“Patient safety is the MHRA’s top priority and we continually monitor the safety and efficacy of all licensed medicines. For the vast major…